Eye drops slow nearsightedness progression in kids, study finds
The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon.
Jun 1, 2023
1
104
The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon.
Jun 1, 2023
1
104
About two-thirds of the risk for Alzheimer's disease (AD) is thought to arise from genetic influences, but about a third could be influenced by environment and lifestyle, opening the door for behavioral interventions that ...
May 31, 2023
0
46
In recent years, there has been greater awareness of the heart-brain connection, or the impact of cardiovascular function on brain health and cognition.
May 31, 2023
0
3
Dementia is defined as the loss of cognitive functioning—including thinking, remembering, and reasoning—and is very prevalent in Japan. Currently, the treatment satisfaction for dementia is among the lowest and no drug ...
May 29, 2023
0
52
A little-known and poorly understood sleep disorder that occurs during the rapid eye movement, or REM, stage of sleep has been garnering attention for its role in foreshadowing neurodegenerative brain diseases such as Parkinson's ...
May 26, 2023
0
10
A new University of Maryland School of Public Health study reveals how walking strengthens connections within and between three of the brain's networks, including one associated with Alzheimer's disease, adding to the growing ...
May 25, 2023
0
31
A University of California, Irvine-led team of researchers has discovered that the oldest-old, those who live to be 90+ and have superior cognitive skills, have similar levels of brain pathology as Alzheimer's patients, however, ...
May 24, 2023
0
31
Blood vessel abnormalities in the eye are a major factor in the progression of Alzheimer's disease, according to research from Cedars-Sinai investigators published in the journal Alzheimer's & Dementia. These changes correspond ...
May 19, 2023
0
57
For schizophrenia patients with tardive dyskinesia (TD), there may be sex differences in cognitive impairment, with a protective effect suggested by female gender, according to a study published in the May issue of Schizophrenia ...
May 19, 2023
0
14
If eligible patients received lecanemab, Medicare would spend an extra $2.0 to $5.1 billion annually, according to a research letter published online May 11 in JAMA Internal Medicine to coincide with the annual meeting of ...
May 18, 2023
0
5